Skip to main content
Subscribe
Sign in
Menu
Membership
Events
Knowledge Center
About
Register
Search
Sign In
Sign In
Register
Subscribe
Hedge Funds
Latest Articles
Biopharma Hedge Funds Diverge in March as Avoro Surges
Stephen Taub
April 20, 2026
For Members Only
Inside Glenview’s Midmonth Reversal
Stephen Taub
April 16, 2026
For Members Only
Greenlight’s Recovery Trade Pays Off
Stephen Taub
April 15, 2026
After a Record Year, TCI Hits a Speed Bump
Stephen Taub
April 14, 2026
For Members Only
Discovery’s Defensive Playbook Pays Off Despite March Loss
Stephen Taub
April 13, 2026
For Members Only
Third Point Cycles Through New Top Positions as Returns Struggle
Stephen Taub
April 8, 2026
For Members Only
Light Street Falls in March as War Turmoil Rattles Equities
Stephen Taub
April 6, 2026
For Members Only
Venture Capital Sets All‑Time Quarterly Record on Unprecedented AI Funding
Stephen Taub
April 2, 2026
For Members Only
Greenlight Suffers Setback in March
Stephen Taub
April 1, 2026
For Members Only
Health Care Hedge Fund Closing Down
Stephen Taub
March 30, 2026
For Members Only
RA Capital Preps New Biotech SPAC — With an Eye on China’s Risks
Stephen Taub
March 27, 2026
For Members Only
Coatue’s Unicorn Spree Marks Its Busiest VC Quarter in Nearly Four Years
Stephen Taub
March 26, 2026
For Members Only
Tigers Burning Bright
Stephen Taub
March 24, 2026
Coatue, Tiger Global, and Rosie
Stephen Taub
March 19, 2026
For Members Only
Seligman Bets Carvana’s High-Flying Stock Won’t Hold Up
Stephen Taub
March 17, 2026
Bill Ackman’s Pershing Square Is Losing Money, but He’s Still Asking Investors for More
Michelle Celarier
March 16, 2026
For Members Only
Valiant’s Long‑Short Fund and Power SPV Jump Again as Firm Preps to Shut SPV to New Capital
Stephen Taub
March 16, 2026
For Members Only
Discovery Surges as Citrone Bets Against the U.S. Market
Stephen Taub
March 12, 2026
More Articles